These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 26121976)

  • 1. Anticancer drug sensitivity prediction in cell lines from baseline gene expression through recursive feature selection.
    Dong Z; Zhang N; Li C; Wang H; Fang Y; Wang J; Zheng X
    BMC Cancer; 2015 Jun; 15():489. PubMed ID: 26121976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison and validation of genomic predictors for anticancer drug sensitivity.
    Papillon-Cavanagh S; De Jay N; Hachem N; Olsen C; Bontempi G; Aerts HJ; Quackenbush J; Haibe-Kains B
    J Am Med Inform Assoc; 2013; 20(4):597-602. PubMed ID: 23355484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational identification of multi-omic correlates of anticancer therapeutic response.
    Stetson LC; Pearl T; Chen Y; Barnholtz-Sloan JS
    BMC Genomics; 2014; 15 Suppl 7(Suppl 7):S2. PubMed ID: 25573145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved anticancer drug response prediction in cell lines using matrix factorization with similarity regularization.
    Wang L; Li X; Zhang L; Gao Q
    BMC Cancer; 2017 Aug; 17(1):513. PubMed ID: 28768489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Data Mining Approaches for Genomic Biomarker Development: Applications Using Drug Screening Data from the Cancer Genome Project and the Cancer Cell Line Encyclopedia.
    Covell DG
    PLoS One; 2015; 10(7):e0127433. PubMed ID: 26132924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DISIS: prediction of drug response through an iterative sure independence screening.
    Fang Y; Qin Y; Zhang N; Wang J; Wang H; Zheng X
    PLoS One; 2015; 10(3):e0120408. PubMed ID: 25794193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
    Barretina J; Caponigro G; Stransky N; Venkatesan K; Margolin AA; Kim S; Wilson CJ; Lehár J; Kryukov GV; Sonkin D; Reddy A; Liu M; Murray L; Berger MF; Monahan JE; Morais P; Meltzer J; Korejwa A; Jané-Valbuena J; Mapa FA; Thibault J; Bric-Furlong E; Raman P; Shipway A; Engels IH; Cheng J; Yu GK; Yu J; Aspesi P; de Silva M; Jagtap K; Jones MD; Wang L; Hatton C; Palescandolo E; Gupta S; Mahan S; Sougnez C; Onofrio RC; Liefeld T; MacConaill L; Winckler W; Reich M; Li N; Mesirov JP; Gabriel SB; Getz G; Ardlie K; Chan V; Myer VE; Weber BL; Porter J; Warmuth M; Finan P; Harris JL; Meyerson M; Golub TR; Morrissey MP; Sellers WR; Schlegel R; Garraway LA
    Nature; 2012 Mar; 483(7391):603-7. PubMed ID: 22460905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Open source machine-learning algorithms for the prediction of optimal cancer drug therapies.
    Huang C; Mezencev R; McDonald JF; Vannberg F
    PLoS One; 2017; 12(10):e0186906. PubMed ID: 29073279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prioritization of anticancer drugs against a cancer using genomic features of cancer cells: A step towards personalized medicine.
    Gupta S; Chaudhary K; Kumar R; Gautam A; Nanda JS; Dhanda SK; Brahmachari SK; Raghava GP
    Sci Rep; 2016 Mar; 6():23857. PubMed ID: 27030518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative and personalized QSAR analysis in cancer by kernelized Bayesian matrix factorization.
    Ammad-ud-din M; Georgii E; Gönen M; Laitinen T; Kallioniemi O; Wennerberg K; Poso A; Kaski S
    J Chem Inf Model; 2014 Aug; 54(8):2347-59. PubMed ID: 25046554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting breast cancer drug response using a multiple-layer cell line drug response network model.
    Huang S; Hu P; Lakowski TM
    BMC Cancer; 2021 May; 21(1):648. PubMed ID: 34059012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal drug prediction from personal genomics profiles.
    Sheng J; Li F; Wong ST
    IEEE J Biomed Health Inform; 2015 Jul; 19(4):1264-70. PubMed ID: 25781964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precise prediction of multiple anticancer drug efficacy using multi target regression and support vector regression analysis.
    Brindha GR; Rishiikeshwer BS; Santhi B; Nakendraprasath K; Manikandan R; Gandomi AH
    Comput Methods Programs Biomed; 2022 Sep; 224():107027. PubMed ID: 35914385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. kESVR: An Ensemble Model for Drug Response Prediction in Precision Medicine Using Cancer Cell Lines Gene Expression.
    Majumdar A; Liu Y; Lu Y; Wu S; Cheng L
    Genes (Basel); 2021 May; 12(6):. PubMed ID: 34070793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of bypass signaling in EGFR pathway and profiling of bypass genes for predicting response to anticancer EGFR tyrosine kinase inhibitors.
    Zhang J; Jia J; Zhu F; Ma X; Han B; Wei X; Tan C; Jiang Y; Chen Y
    Mol Biosyst; 2012 Oct; 8(10):2645-56. PubMed ID: 22833077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Trends in Drug Sensitivity Prediction.
    Cortes-Ciriano I; Mervin LH; Bender A
    Curr Pharm Des; 2016; 22(46):6918-6927. PubMed ID: 27784247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond the limitation of targeted therapy: Improve the application of targeted drugs combining genomic data with machine learning.
    Miao R; Chen HH; Dang Q; Xia LY; Yang ZY; He MF; Hao ZF; Liang Y
    Pharmacol Res; 2020 Sep; 159():104932. PubMed ID: 32473309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Explainable drug sensitivity prediction through cancer pathway enrichment.
    Tang YC; Gottlieb A
    Sci Rep; 2021 Feb; 11(1):3128. PubMed ID: 33542382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting cancer drug response by proteomic profiling.
    Ma Y; Ding Z; Qian Y; Shi X; Castranova V; Harner EJ; Guo L
    Clin Cancer Res; 2006 Aug; 12(15):4583-9. PubMed ID: 16899605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive anticancer drug response prediction based on a simple cell line-drug complex network model.
    Wei D; Liu C; Zheng X; Li Y
    BMC Bioinformatics; 2019 Jan; 20(1):44. PubMed ID: 30670007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.